{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T10:55:24Z","timestamp":1759056924642},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1998,1]]},"DOI":"10.1212\/wnl.50.1.217","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:31:39Z","timestamp":1336915899000},"page":"217-223","source":"Crossref","is-referenced-by-count":8,"title":["Optic neuritis and cytokines"],"prefix":"10.1212","volume":"50","author":[{"given":"P.","family":"Kivisa\u0308kk","sequence":"first","affiliation":[{"name":"From the Divisions of Neurology (Drs. Kivisa\u0308kk, Tian, Matusevicius, and Link) and Ophthalmology (Dr. So\u0308derstro\u0308m), Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Tian","sequence":"additional","affiliation":[{"name":"From the Divisions of Neurology (Drs. Kivisa\u0308kk, Tian, Matusevicius, and Link) and Ophthalmology (Dr. So\u0308derstro\u0308m), Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Matusevicius","sequence":"additional","affiliation":[{"name":"From the Divisions of Neurology (Drs. Kivisa\u0308kk, Tian, Matusevicius, and Link) and Ophthalmology (Dr. So\u0308derstro\u0308m), Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Link","sequence":"additional","affiliation":[{"name":"From the Divisions of Neurology (Drs. Kivisa\u0308kk, Tian, Matusevicius, and Link) and Ophthalmology (Dr. So\u0308derstro\u0308m), Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"So\u0308dersto\u0308m","sequence":"additional","affiliation":[{"name":"From the Divisions of Neurology (Drs. Kivisa\u0308kk, Tian, Matusevicius, and Link) and Ophthalmology (Dr. So\u0308derstro\u0308m), Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","first-page":"2","volume":"84","year":"1991","unstructured":"Martinelli V, Comi G, Filippi M, et al. Paraclinical tests in acute onset optic neuritis: basal data and results of a short follow up. Acta Neurol Scand 1991;84:231-236.","journal-title":"Acta Neurol Scand"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/116.1.1"},{"key":"e_1_3_1_4_2","first-page":"3","volume":"241","year":"1994","unstructured":"S\u00f6derstr\u00f6m M, Lindqvist M, Hillert J, K\u00e4ll T-B, Link H. Optic neuritis: findings on MRI, CSF examinations and HLA class II typing in 60 patients and results of a short-term follow-up. J Neurol 1994;241:391-397.","journal-title":"J Neurol"},{"key":"e_1_3_1_5_2","first-page":"2","volume":"85","year":"1996","unstructured":"Steinman L. Multiple sclerosis: a co-ordinated immunological attack against myelin in the central nervous system. Cell 1996;85:299-302.","journal-title":"Cell"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410360103"},{"key":"e_1_3_1_7_2","first-page":"7","volume":"44","year":"1994","unstructured":"Link J, S\u00f6derstr\u00f6m M, Ljungdahl \u00c5, et al. Organ-specific autoantigens induce interferon-\u03b3 and interleukin-4 mRNA expression in multiple sclerosis and myasthenia gravis. Neurology 1994;44:728-734.","journal-title":"Neurology"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410350102"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.1995.tb03526.x"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.44.1.1"},{"key":"e_1_3_1_11_2","first-page":"2","volume":"119","year":"1996","unstructured":"Navikas V, He B, Link J, et al. Augmented expression of tumor necrosis factor-\u03b1 and lymphotoxin mRNA in mononuclear cells in multiple sclerosis and optic neuritis. Brain 1996;119:213-213.","journal-title":"Brain"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.37.1.1"},{"key":"e_1_3_1_13_2","first-page":"4","volume":"325","year":"1991","unstructured":"Sharief MK, Hentges R. Association between tumor necrosis factor-\u03b1 and disease progression in patients with multiple sclerosis. N Engl J Med 1991;325:467-472.","journal-title":"N Engl J Med"},{"key":"e_1_3_1_14_2","doi-asserted-by":"crossref","unstructured":"Link J S\u00f6derstr\u00f6m M Kostulas V et al. Optic neuritis is associated with myelin basic protein and proteolipid protein reactive cells producing interferon-\u03b3 interleukin-4 and transforming growth factor-\u03b2 J. Neuroimmunol 1994d;49:9-18.","DOI":"10.1016\/0165-5728(94)90175-9"},{"key":"e_1_3_1_15_2","first-page":"1","volume":"16","year":"1995","unstructured":"S\u00f6derstr\u00f6m M. The clinical and paraclinical profile of optic neuritis. a prospective study. Ital J Neurol Sci 1995;16:167-176.","journal-title":"Ital J Neurol Sci"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.38.1.1"},{"key":"e_1_3_1_17_2","first-page":"2","volume":"30","year":"1984","unstructured":"Olsson T, Kostulas V, Link H. Improved detection of oligoclonal IgG in cerebrospinal fluid by isoelectric focusing in agarose, double antibody peroxidase labelling, and avidin-biotin amplification. Clin Chem 1984;30:246-249.","journal-title":"Clin Chem"},{"key":"e_1_3_1_18_2","first-page":"1","volume":"2","year":"1972","unstructured":"Deibler GE, Martensson RE, Kies MV. Large scale preparation of myelin basic protein from central nervous tissue of several animal species. Prep Biochem 1972;2:139-165.","journal-title":"Prep Biochem"},{"key":"e_1_3_1_19_2","first-page":"4","volume":"312","year":"1984","unstructured":"Pennica D, Nedwin GE, Hayflick JS, et al. Human tumor necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 1984;312:452-457.","journal-title":"Nature"},{"key":"e_1_3_1_20_2","first-page":"7","volume":"312","year":"1984","unstructured":"Gray PW, Aggarwal BB, Benton CV. Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumor necrosis activity. Nature 1984;312:721-724.","journal-title":"Nature"},{"key":"e_1_3_1_21_2","first-page":"4","volume":"88","year":"1991","unstructured":"Gubler U, Chua AD, Schoenhaut DS, et al. Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc Natl Acad Sci USA 1991;88:4143-4147.","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.1.1"},{"key":"e_1_3_1_23_2","first-page":"5","volume":"83","year":"1986","unstructured":"Yokota T, Otsuka T, Mosmann T, et al. Isolation and characterisation of a human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that expresses B-cell and T-cell stimulating activities. Proc Natl Acad Sci USA 1986;83:5894-5898.","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_1_24_2","first-page":"7","volume":"316","year":"1985","unstructured":"Derynck R, Jarett JA, Chen EY, et al. Human transforming growth factor-\u03b2 complementary DNA sequence and expression in normal and transformed cells. Nature 1985;316:701-705.","journal-title":"Nature"},{"key":"e_1_3_1_25_2","first-page":"5","volume":"40","year":"1995","unstructured":"Issazadeh S, Mustafa MI, Ljungdahl \u00c5, et al. Interferon-\u03b3, interleukin-4 and transforming growth factor-\u03b2 in experimental allergic encephalomyelitis in Lewis rats: dynamics of cellular mRNA expression in the central nervous system and lymphoid cells. J Neurosci Res 1995;40:579-590.","journal-title":"J Neurosci Res"},{"key":"e_1_3_1_26_2","first-page":"2","volume":"61","year":"1995","unstructured":"Issazadeh S, Ljungdahl \u00c5, H\u00f6jeberg B, Mustafa M, Olsson T. Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis: dynamics of mRNA expression for interleukin 10, interleukine 12, cytolysin, tumor necrosis factor- and tumor necrosis factor-\u03b2. J Neuroimmunol 1995;61:205-212.","journal-title":"J Neuroimmunol"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1985.04060010010002"},{"key":"e_1_3_1_28_2","first-page":"6","volume":"43","year":"1993","unstructured":"The IFN-\u03b2 Multiple Sclerosis Study Group. Interferon-beta-1b is effective in relapsing remitting multiple sclerosis. Clinical results of a multicenter, randomised, double-blind, placebo controlled trial. Neurology 1993;43:655-661.","journal-title":"Neurology"},{"key":"e_1_3_1_29_2","first-page":"2","volume":"39","year":"1996","unstructured":"Jacobs LD, Cookfair DL, Rudick RA, et al. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. Ann Neurol 1996;39:285-294.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_30_2","first-page":"7","volume":"1","year":"1995","unstructured":"Vartanian T, Li Y, Zhao M, Stefansson K. Interferon-\u03b3-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis. Mol Med 1995;1:732-743.","journal-title":"Mol Med"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.1.1"},{"key":"e_1_3_1_32_2","first-page":"2","volume":"76","year":"1994","unstructured":"Paul WE, Seder RA. Lymphocyte responses and cytokines. Cell 1994;76:241-251.","journal-title":"Cell"},{"key":"e_1_3_1_33_2","first-page":"3","volume":"142","year":"1989","unstructured":"Essner R, Rhoades K, McBride WH, et al. IL-4 down-regulates IL-1 and TNF gene expression on human monocytes. J Immunol 1989;142:3857-3861.","journal-title":"J Immunol"},{"key":"e_1_3_1_34_2","first-page":"6","volume":"144","year":"1990","unstructured":"Abramson SL, Gallin JI. IL-4 inhibits superoxide production by human mononuclear phagocytes. J Immunol 1990;144:625-630.","journal-title":"J Immunol"},{"key":"e_1_3_1_35_2","first-page":"2","volume":"58","year":"1995","unstructured":"Link J, Bing H, Navikas V, et al. TGF-\u03b21 suppresses autoantigen-induced expression of proinflammatory cytokines but not IL-10 in multiple sclerosis and myasthenia gravis. J Neuroimmunol 1995;58:21-35.","journal-title":"J Neuroimmunol"},{"key":"e_1_3_1_36_2","first-page":"3","volume":"21","year":"1988","unstructured":"Selmaj K, Raine CS. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 1988;21:339-346.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_37_2","first-page":"4","volume":"10","year":"1992","unstructured":"Vassali IP. The pathophysiology of tumor necrosis factors. Annu Rev Immunol 1992;10:411-452.","journal-title":"Annu Rev Immunol"},{"key":"e_1_3_1_38_2","first-page":"6","volume":"42","year":"1992","unstructured":"Thompson AJ, Miller D, Youl B, et al. Serial gadolinium enhanced MRI in relapsing\/remitting multiple sclerosis of varying disease duration. Neurology 1992;42:60-63.","journal-title":"Neurology"},{"key":"e_1_3_1_39_2","first-page":"5","volume":"96","year":"1994","unstructured":"Navikas V, Link J, Wahren B, Persson C, Link H. Increased levels of IFN-\u03b3, IL-4 and TGF-\u03b2 mRNA expressing blood mononuclear cells in human HIV infection. Clin Exp Immunol 1994;96:59-63.","journal-title":"Clin Exp Immunol"},{"key":"e_1_3_1_40_2","doi-asserted-by":"crossref","unstructured":"Navikas V Haglund M Link J et al. Cytokine mRNA profiles in mononuclear cells in acute aseptic meningoencephalitis. Infect Immun 1995b;63:1581-1583.","DOI":"10.1128\/iai.63.4.1581-1586.1995"},{"key":"e_1_3_1_41_2","first-page":"1","volume":"88","year":"1992","unstructured":"Wang W-Z, Olsson T, Kostulas V, H\u00f6jeberg B, Ekre H-P, Link H. Myelin antigen reactive T cells in cerebrovascular disease. Clin Exp Immunol 1992;88:157-162.","journal-title":"Clin Exp Immunol"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.50.1.217","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T15:21:14Z","timestamp":1711639274000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.50.1.217"}},"subtitle":["No relation to MRI abnormalities and oligoclonal bands"],"short-title":[],"issued":{"date-parts":[[1998,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,1]]}},"alternative-id":["10.1212\/WNL.50.1.217"],"URL":"https:\/\/doi.org\/10.1212\/wnl.50.1.217","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,1]]}}}